Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
). The CFIB is a newly created multimodal bioimaging core facility under the new Center for Core Facilities (CCF). CFIB’s vision is to integrate the two existing facilities, the preclinical NMR platform and
-
of extension. https://bionmr.univie.ac.at/people/ Working Environment The NMR facility at the Department of Pharmaceutical Sciences includes: 700 MHz, two 500 MHz, equipped with cryoprobes and SampleJet, open
-
the areas of organic synthesis, organic catalysis, and inert-gas techniques Practical experience in NMR spectroscopy and mass spectrometry Prior experience in computational chemistry and the experimental
-
sensitive to the family needs of faculty, including dual-career couples. For details, visit the following link: http://www.auburn.edu/academic/provost/facultyjobs/. Resources available to support faculty can
-
elucidation by IR, NMR and MS; d) Quality control by HPLC. 4.2. When the academic degree or diploma is awarded during the term of the studentship contracts, the studentship may continue as long as the
-
on the project choice/previous experience/interests, as a PhD student, you will gain hands-on experience in Synthetic chemistry and analytical techniques (HPLC, LC–MS, NMR) Designing and synthesising compounds
-
of the nuclear fuel cycle • Knowledge of uranium and fluorine chemistry • Ability to use multiple material characterization techniques (XRD, NMR, EPR, IR and Raman spectroscopies…) • Intellectual rigor and
-
, synthesis of ligands and mono- and dinuclear platinum(II) complexes, structural characterisation and assessment of purity of final products and intermediates using popular techniques like NMR or mass
-
Chemical Biological Centre (https://www.umu.se/en/kbc ) at Umeå University and is affiliated with the national Centre of Excellence – Umeå Centre for Microbial Research (UCMR) (https://www.umu.se/en/ucmr
-
production. Experience in molecular characterization using TLC, HPLC, NMR, Mass, etc. Experience working with different radioisotopes for diagnostic and therapeutic radiopharmaceutical development. Preferred